Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Marwitz, M. Abdullah, C. Vock, J.S. Fine, S. Visvanathan, K.I. Gaede, P. Zabel, T. Goldmann (Borstel, Germany; Nutley, United States Of America). HOPE-BAL: A novel tool to expand the methodological capabilities in pulmonary research. Eur Respir J 2012; 40: Suppl. 56, 771

Member's Comments

No comment yet.

Related content which might interest you: There is no rationale to still rely on outdated, biased tools for quantitative morphology in pulmonary research Source: Eur Respir Rev 2006; 15: 105-106 Year: 2006 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 Revising our approach to conducting therapeutic clinical research in COPD Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017 Year: 2018 From the bedside: upcoming new clinical strategies Source: International Congress 2016 – Scientific Year in Review 2016 Year: 2016 Methodological approach to the development of a learning needs assessment tool Source: International Congress 2018 – Acutely hospitalised patients: physiotherapy interventions and assessment methods Year: 2018 Developing a novel in vitro 3D airway model to provide a viable alternative to animal use in asthma research Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 How to build a lung: latest advances and emerging themes in lung bioengineering Source: Eur Respir J, 52 (1) 1601355; 10.1183/13993003.01355-2016 Year: 2018 What do we need in the clinic and what approach can clinicians take to improve the drug development pipeline? Source: ERS Research Seminar 2016 Year: 2016 The limitations of quantitative measures: assessing approaches to research into NIV use in MND Source: Annual Congress 2009 - New trends in noninvasive ventilation for chronic respiratory failure Year: 2009 The era of research collaborations: new models for working together Source: Eur Respir J 2017; 49(1): 1601848; DOI: 10.1183/13993003.01848-2016 Year: 2017 NORDSTAR: paving the way for a new era in asthma research Source: Eur Respir J, 55 (4) 1902476; 10.1183/13993003.02476-2019 Year: 2020 N-ethyl-N-nitrosourea mutagenesis: a new tool for exploring lung disease Source: Annual Congress 2010 - Scientific Year in Review Year: 2010 Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects Source: International Congress 2017 – In the frontline of the fight against tuberculosis Year: 2017 What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis Source: Eur Respir Monogr 2018; 82: 414-429 Year: 2018 Respiratory monitoring: revisiting classical physiological principles with new tools Source: Eur Respir J 2004; 24 : 718-719 Year: 2004 A global strategy for tuberculosis research and innovation Source: Eur Respir J, 56 (5) 2003539; 10.1183/13993003.03539-2020 Year: 2020 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 Development of a pulmonary nodule service & clinical pathway: A pragmatic approach addressing an unmet need Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Exploring new frontiers: the role of simulation as an educational strategy Source: Breathe 2013; 9: 497-501 Year: 2013